BRM.F

Bristol-Myers Squibb Company
FrankfurtEUREQUITY Healthcare DELAYED
Last price
56.13
▼ 0.47 (0.83%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
55.57
Prev close
56.60
Day high
56.13
Day low
55.46
Volume
176
Market cap
$114.66B
P/E (TTM)
14.47
52W range
36.65 – 60.64

Day trading desk

Current session · delayed
Gap from prior close
-1.82%
Prior close 56.60
VWAP
56.12
+0.03% from price
Relative volume
0.38×
Quiet session
Session range
1.21%
55.46 – 56.13
Position in range
100%
Near session high
ATR (14D)
1.22
2.16% of price
Prior day high
57.84
PDH
Prior day low
56.60
PDL
Bid / ask spread
Quote not published
Session volume
180
Avg 468

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+2.56% +3.9%
1M
+5.13% +1.4%
3M
+12.89% +9.8%
6M
+8.82% -2.2%
YTD
+23.12% +10.8%
1Y
+34.30% +14.3%
3Y
-2.72% -76.9%
5Y
+5.31%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on BRM.F open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
2.02M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 31, 26
GALLMAN CARI
General Counsel
1.06K Direct
Jul 31, 26
MASSACESI CRISTIAN
Officer
51.17K Direct
Jun 15, 26
HALLER JULIA A
Director
CONVERSION 20.46K $1.10M Direct
Jun 3, 26
SHORT BARTIE WENDY
Officer
8.04K Direct
May 1, 26
LENKOWSKY ADAM
Officer
1.37K Direct
Apr 1, 26
ELKINS DAVID VINCENT
Chief Financial Officer
SELL 30.00K $1.85M Direct
Apr 1, 26
SHANAHAN KARIN
Officer
3.31K Direct
Mar 10, 26
PLENGE ROBERT M
Officer
17.50K Direct
Mar 10, 26
MEYERS GREGORY SCOTT
Chief Technology Officer
25.89K Direct
Mar 10, 26
SHANAHAN KARIN
Officer
25.50K Direct
Mar 10, 26
LENKOWSKY ADAM
Officer
24.07K Direct
Mar 10, 26
GALLMAN CARI
General Counsel
6.98K Direct
Mar 10, 26
HOCH LYNELLE BAUMGARDNER
Officer
8.19K Direct
Mar 10, 26
POOLE AHN AMANDA
Officer
6.44K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BOERNER CHRISTOPHER S
Chief Executive Officer 146.89K Conversion of Exercise of derivative security
ELKINS DAVID VINCENT
Chief Financial Officer 159.54K Sale
HALLER JULIA A
Director 34.08K Conversion of Exercise of derivative security
HIRAWAT SAMIT
Officer 83.51K Purchase
LENKOWSKY ADAM
Officer 28.68K Conversion of Exercise of derivative security
LEUNG SANDRA
General Counsel 465.37K Conversion of Exercise of derivative security
MASSACESI CRISTIAN
Officer 25.00K Conversion of Exercise of derivative security
MEYERS GREGORY SCOTT
Chief Technology Officer 30.36K Conversion of Exercise of derivative security
PLENGE ROBERT M
Officer 24.75K Conversion of Exercise of derivative security
SHANAHAN KARIN
Officer 27.34K Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap$114.66B
Enterprise value$148.64B
Revenue (TTM)$49.19B
Gross profit$35.25B
EBITDA$18.93B
Net income$9.28B
EPS (TTM)$3.88
Free cash flow$8.11B
Total cash$11.07B
Total debt$45.05B
Book value / share$9.35
Shares outstanding2.04B
Float2.04B
Short % of float
Dividend yield3.89%
Beta (5Y)0.23

Valuation & profitability ratios

Account required
Trailing P/E14.47
Forward P/E
PEG ratio2.32
Price / sales
Price / book6.00
EV / revenue3.02
EV / EBITDA7.85
Gross margin71.66%
Operating margin34.42%
Profit margin18.87%
Return on equity46.60%
Return on assets10.72%
Debt / equity201.86
Current ratio1.53
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $48.20B$48.30B$45.01B$46.16B -0.2%
Operating revenue $47.20B$47.26B$44.39B$45.41B -0.1%
Cost of revenue $13.94B$13.97B$10.69B$10.14B -0.2%
Gross profit $34.26B$34.33B$34.31B$36.02B -0.2%
Research & development $9.95B$11.16B$9.30B$9.51B -10.8%
Selling, general & admin $7.27B$8.41B$7.77B$7.81B -13.6%
Total operating expense $20.54B$28.45B$26.12B$26.92B -27.8%
Operating income $13.72B$5.89B$8.20B$9.10B +133.1%
Net interest income -$1.89B-$1.95B-$1.17B-$1.23B +2.9%
Pre-tax income $9.33B-$8.38B$8.44B$7.71B +211.3%
Tax provision $2.27B$554.00M$400.00M$1.37B +310.1%
Net income $7.05B-$8.95B$8.03B$6.33B +178.8%
Net income to common $7.05B-$8.95B$8.03B$6.33B +178.8%
Basic EPS 3.47-4.413.882.97 +178.7%
Diluted EPS 3.46-4.413.862.95 +178.5%
EBIT $11.22B-$6.43B$9.61B$8.95B +274.4%
EBITDA $15.23B$3.17B$19.37B$19.22B +380.7%
Basic shares 2.03B2.03B2.07B2.13B +0.3%
Diluted shares 2.04B2.03B2.08B2.15B +0.6%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $12.66B +3.6%
Next quarter $12.70B +1.6%
Current year $49.85B +3.4%
Next year $48.13B -3.4%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.10%
Held by institutions84.69%
Institutions holding3.27K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
55.84
+0.51% from price
SMA 20
55.73
+0.73% from price
SMA 50
52.52
+6.87% from price
SMA 100
50.93
+10.22% from price
SMA 200
49.06
+14.42% from price
EMA 12
55.93
+0.35% from price
EMA 26
54.88
+2.27% from price
EMA 50
53.40
+5.11% from price
RSI (14)
55.5
Neutral
MACD (12,26,9)
1.05
Hist -0.05
ATR (14)
1.22
2.16% of price
Realised vol 30D
31.8%
Annualised
Bollinger upper
57.66
20, 2σ
Bollinger lower
53.79
20, 2σ
50 / 200 cross
Golden
52.52 vs 49.06
Trend bias
Above 200
+14.42%

Options chain

Account required
ExpirySpot 56.13
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.15
Less volatile than market
Correlation to SPY
-0.07
Largely independent
Realised vol 30D
31.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-12.4%
Peak to trough
Max drawdown 5Y
-54.5%
Peak to trough
ATR 14
1.22
2.16% of price
Beta (reported)
0.23
5Y monthly, from filing

Rating changes

297 on file
DateFirm ActionFromTo
Aug 5, 26 Argus Research UPGRADE Hold Buy
Aug 3, 26 Citigroup MAINTAINED Neutral Neutral
Jul 31, 26 RBC Capital MAINTAINED Sector Perform Sector Perform
Jul 31, 26 JP Morgan MAINTAINED Overweight Overweight
Jul 31, 26 Cantor Fitzgerald MAINTAINED Neutral Neutral
Jul 31, 26 Wells Fargo MAINTAINED Equal-Weight Equal-Weight
Jul 31, 26 Guggenheim MAINTAINED Buy Buy
Jul 31, 26 Truist Securities MAINTAINED Buy Buy
Jul 10, 26 B of A Securities MAINTAINED Buy Buy
Jul 6, 26 Cantor Fitzgerald MAINTAINED Neutral Neutral
Apr 9, 26 B of A Securities MAINTAINED Buy Buy
Apr 8, 26 Guggenheim MAINTAINED Buy Buy

Dividends & splits

Declared · from the issuer
Forward rate$2.18 / yr
Forward yield3.89%
5-year avg yield4.00%
Payout ratio55.29%
Ex-dividend dateJul 2, 2026
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.